SPRY Archived Articles
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY): Revolutionizing Allergy Treatment with Needle-Free Epinephrine
Published on March 14, 2025
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY): Navigating the Intranasal Epinephrine Landscape
Published on September 24, 2024